dms retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation What is Retatrutide treatment: Boost
Description
2009 In the fall of 2008, with guidance from experts in survey methods and design from NORC, we reviewed the methods used for the survey

It is quick, cheap, and easy

The GIP component enhances insulin secretion in response to meals while also appearing to buffer some of the nausea commonly associated with GLP-1 activation
[DOI] [PubMed] [Google Scholar] Hamer M, Witte DR, Mosdl A, Marmot MG, Brunner EJ

Clinical trials (SURMOUNT-1, NEJM 2022) showed average weight loss of 2022% of body weight, making it the most powerful GLP-1 option currently available

Prevention requires effort but is far easier than reversing established hair loss
